Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion type Assertion NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_head.
- NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion description "[Combined therapy of cisplatin and ATP11B-targeted siRNA significantly decreased cancer growth in mice bearing ovarian tumors derived from cisplatin-sensitive and -resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_provenance.
- NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion evidence source_evidence_literature NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_provenance.
- NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion SIO_000772 23585472 NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_provenance.
- NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion wasDerivedFrom befree-20140225 NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_provenance.
- NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_assertion wasGeneratedBy ECO_0000203 NP787883.RAO1ENicxA22pj4s9UeKawqXqf_488uoDkgrwxlEK9m98130_provenance.